Published in Clin Immunol Immunopathol on May 01, 1976
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest (2006) 0.90
Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Arch Dermatol Res (2007) 0.81
Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor. Clin Exp Immunol (1981) 0.75
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha. J Invest Dermatol (1976) 1.30
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Cutaneous periarteritis nodosa. Arch Dermatol (1974) 1.19
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
Disabling pansclerotic morphea of children. Arch Dermatol (1980) 1.11
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Herpes gestationis. New immunologic findings. Arch Dermatol (1974) 0.99
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Successful treatment of cutaneous PAN with pentoxifylline. Br J Dermatol (1993) 0.94
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Cutaneous periarteritis nodosa: immunofluorescence studies. Arch Dermatol (1980) 0.93
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol (1986) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
"An unusual type of pemphigus combining features of lupus erythematosus" by Senear and Usher, June 1926. Commentary: Pemphigus erythematosus, a unique member of the pemphigus group. Arch Dermatol (1982) 0.88
Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol (1984) 0.87
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med (1976) 0.87
Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage. Br J Dermatol (1978) 0.86
Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med (1990) 0.86
The complement system in pemphigus, bullous pemphigoid and herpes gestationis. Int J Dermatol (1979) 0.86
Pemphigus-like antibodies in bullous pemphigoid. Arch Dermatol (1977) 0.85
Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus. Br J Dermatol (1975) 0.85
Immunofluorescent studies of dermatomyositis. Dermatologica (1972) 0.82
Livedo vasculitis (the vasculitis of atrophie blanche). Immunohistopathologic study. Arch Dermatol (1975) 0.82
Neonatal pemphigus foliaceus. Arch Dermatol (1995) 0.82
Immunopathology of cicatricial pemphigoid: studies of complement deposition. J Invest Dermatol (1977) 0.82
The particulate (speckled-like thread) nuclear staining pattern: species and cellular distribution of Ro/SSA antigen. J Clin Lab Immunol (1987) 0.82
An appraisal of routine direct immunofluorescence in vulvar disorders. Acta Derm Venereol (1981) 0.81
Complement fixation by Brazilian Pemphigus foliaceus autoantibodies. Clin Exp Immunol (1988) 0.81
Neonatal lupus erythematosus. A report of three cases associated with anti-Ro/SSA antibodies. Arch Dermatol (1985) 0.81
Expression of pemphigus vulgaris antigen in cultured human keratinocytes: effect of inhibitors, tunicamycin, and lectins. J Invest Dermatol (1988) 0.80
Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol (1983) 0.80
Clq binding activity in lupus erythematosus: correlation with the "lupus band test". J Invest Dermatol (1978) 0.80
Immunopathology of oral mucosal inflammatory diseases. Clin Exp Dermatol (1977) 0.79
Concurrent linear scleroderma and systemic lupus erythematosus: a report of two cases. J Invest Dermatol (1979) 0.79
Immunofluorescence of epithelial skin tumors. II. Basement membrane. Cancer (1970) 0.79
Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen. J Lab Clin Med (1988) 0.79
Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. J Clin Invest (1988) 0.79
Bullous pemphigoid associated with systemic lupus erythematosus. Arch Dermatol (1969) 0.78
Circulating immune complexes in systemic scleroderma and generalized morphea. Dermatologica (1980) 0.78
Reversible cutis laxa due to maternal D-penicillamine treatment. Lancet (1979) 0.78
The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody. J Invest Dermatol (1980) 0.77
Immunohistochemical studies of the human cutaneous basement membrane-anchoring fibril complex. J Invest Dermatol (1977) 0.77
A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol (1978) 0.77
Giant molluscum contagiosum presenting as a tumor in an HIV-infected patient. Int J Dermatol (1994) 0.77
C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies. Arch Dermatol (1982) 0.77
Anti-Ro/SSA antibodies. Association with a particulate (large speckledlike thread) immunofluorescent nuclear staining pattern. Arch Dermatol (1985) 0.77
Systemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J (1996) 0.77
Pre-Sézary syndrome. J Am Acad Dermatol (1984) 0.77
Cutaneous metastases of hepatocellular carcinoma. Clin Exp Dermatol (2009) 0.76
The immunopathology of pemphigus and bullous pemphigoid. 1968. J Invest Dermatol (1989) 0.76
Immunopathology in pemphigus. Clin Dermatol (1987) 0.76
Demodex mites in rosacea. J Am Acad Dermatol (1994) 0.75
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy. Arch Dermatol (1992) 0.75
Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor. Clin Exp Immunol (1981) 0.75
The surgical applications and implications of cultured human epidermis: a comprehensive review. Surgery (1992) 0.75
Development of photosensitivity and an SLE-like syndrome in a patient with psoriasis. Arch Dermatol (1978) 0.75
PBS-soluble substances with blood group activity from human epidermis and dermis. Acta Derm Venereol (1977) 0.75
Desquamative gingivitis. Clinical, histopathologic, and immunopathologic investigations. Oral Surg Oral Med Oral Pathol (1976) 0.75
Late cutaneous reactions due to IgE antibodies. Monogr Allergy (1977) 0.75
Hypocomplementemic ear effusion in relapsing polychondritis. Mayo Clin Proc (1976) 0.75
Hypogonadotrophic hypogonadism with hyposmia, X-linked ichthyosis, and renal malformation syndrome. Clin Endocrinol (Oxf) (1995) 0.75
[Chemotactic activity in the fluid of bullous pemphigoid blisters]. Med Cutan Ibero Lat Am (1975) 0.75